Expression of CXCR3 was increased on all lymphoid subsets in both tumor deposits, complementing our in vitro data (porta hepatis 1,581 ± 504.3 vs. 3,899 ± 432.3 MFI on CD8+ cells, P = 0.0049; omentum 2,485 ± 204.0 vs. 4,012 ± 273.6 MFI on CD8+ cells, P = 0.0005, Fig. 5H and I). This evidence concerns the gene CXCR3 and neoplasm.